Land: Storbritannia
Språk: engelsk
Kilde: MHRA (Medicines & Healthcare Products Regulatory Agency)
Cefuroxime axetil
Sandoz Ltd
J01DC02
Cefuroxime axetil
250mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010201; GTIN: 5050650009019
PACKAGE LEAFLET: INFORMATION FOR THE PATIENT SZ00000LT000 WHAT IS IN THIS LEAFLET: 1. What Cefuroxime is and what it is used for 2. What you need to know before you take Cefuroxime 3. How to take Cefuroxime 4. Possible side effects 5. How to store Cefuroxime 6. Contents of the pack and other information Cefuroxime is an antibiotic used in adults and children. It works by killing bacteria that cause infections. It belongs to a group of medicines called _cephalosporins._ Cefuroxime is used to treat infections of: • the throat • sinus • middle ear • the lungs or chest • the urinary tract • the skin and soft tissues. Cefuroxime can also be used: • to treat Lyme disease (an infection spread by parasites called ticks). DO NOT TAKE CEFUROXIME: • IF YOU ARE ALLERGIC to cefuroxime, to ANY CEPHALOSPORIN ANTIBIOTICS or any of the other ingredients of this medicine (listed in section 6). • if you have ever had a severe allergic (hypersensitive) reaction to any other type of betalactam antibiotic (penicillins, monobactams and carbapenems). If you think this applies to you, DON’T TAKE Cefuroxime until you have checked with your doctor. WARNINGS AND PRECAUTIONS Talk to your doctor, pharmacist or nurse before using Cefuroxime. Cefuroxime IS NOT RECOMMENDED FOR CHILDREN AGED UNDER 3 MONTHS, as the safety and effectiveness are not known in this age group. You must look out for certain symptoms, such as allergic reactions, fungal infections (such as _candida_) and severe diarrhoea _(pseudomembranous colitis)_ while you are taking Cefuroxime. This will reduce the risk of any problems. See ‘Conditions you need to look out for’ in Section 4. IF YOU NEED A BLOOD TEST Cefuroxime can affect the results of a test for blood sugar levels, or a blood screen called the _Coombs test._ If you need a blood test: TELL THE PERSON TAKING THE SAMPLE that you are taking Cefuroxime. OTHER MEDICINES AND CEFUROXIME Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicine. This read_full_document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Cefuroxime 250mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 250 mg coated tablet contains 300.72 mg cefuroxime (as axetil). For the full list of excipients: see section 6.1. 3 PHARMACEUTICAL FORM Coated tablets White to slightly yellowish, biconvex, oblong tablets scored on both sides. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Cefuroxime axetil is indicated for the treatment of the infections listed below in adults and children from the age of 3 months (see sections 4.4 and 5.1). - Acute streptococcal tonsillitis and pharyngitis. - Acute bacterial sinusitis. - Acute otitis media. - Acute exacerbations of chronic bronchitis. - Cystitis - Pyelonephritis. - Uncomplicated skin and soft tissue infections. - Treatment of early Lyme disease. Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The usual course of therapy is seven days (may range from five to ten days). _Table 1. Adults and children (_ ≥ _40 kg) _ Indication Dosage Acute tonsillitis and pharyngitis, acute bacterial sinusitis 250 mg twice daily Acute otitis media 500 mg twice daily Acute exacerbations of chronic bronchitis 500 mg twice daily Cystitis 250 mg twice daily Pyelonephritis 250 mg twice daily Uncomplicated skin and soft tissue infections 250 mg twice daily Lyme disease 500 mg twice daily for 14 days (range of 10 to 21 days) _Table 2. Children (<40 kg) _ _ _ Indication Dosage Acute tonsillitis and pharyngitis, acute bacterial sinusitis 10 mg/kg twice daily to a maximum of 125 mg twice daily Children aged two years or older with otitis media or, where appropriate, with more severe infections 15 mg/kg twice daily to a maximum of 250 mg twice daily Cystitis 15 mg/kg twice daily to a maximum of 250 mg twice daily Pyelonephritis 15 mg/kg twice daily to a maximum of 250 mg twice daily for 10 to 14 days Uncomplicated skin and soft tissue infections 15 mg/kg twice daily read_full_document